Literature DB >> 8093247

Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha.

G C Blobe1, C W Sachs, W A Khan, D Fabbro, S Stabel, W C Wetsel, L M Obeid, R L Fine, Y A Hannun.   

Abstract

The multidrug resistance (MDR) phenotype induces cross-resistance to many chemotherapeutic agents in cancer cells. Protein kinase C (PKC) has been implicated in the regulation of the MDR phenotype. In order to determine the role of specific PKC isoenzymes in regulating the MDR phenotype, the expression and activity of PKC isoenzymes in the human breast cancer cell line, MCF-7-WT, and an MDR subline, MCF-7-MDR, were examined. The MDR phenotype was associated with a 10-fold increase in calcium-dependent PKC activity as well as a 10-fold decrease in calcium-independent activity was due to a selective increase in the activity was due to a selective increase in the expression of PKC alpha as determined by Western blot analysis and hydroxylapatite chromatography. This increase in expression of PKC alpha was regulated at the message level as demonstrated by Northern blot analysis. The decrease in calcium-independent activity was caused by a decrease in the expression of PCK delta and epsilon. The significance of the increase in PKC alpha expression was then demonstrated by a commensurate 11-fold increase in the basal and stimulated phosphorylation of the myristolated alanine-rich C kinase substrate. Phosphorylation of P-glycoprotein, the cellular mediator of the MDR phenotype, was increased > 20-fold in the unstimulated MCF-7-MDR cell line and its phosphorylation was further increased 2-fold in response to phorbol 12-myristate 13-acetate. These changes paralleled the increases in P-glycoprotein pump function and the MDR phenotype underscoring the role for PKC alpha in regulating P-glycoprotein phosphorylation and function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093247

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration.

Authors:  Nikki A Evensen; Cem Kuscu; Hoang-Lan Nguyen; Kevin Zarrabi; Antoine Dufour; Pournima Kadam; You-Jun Hu; Ashleigh Pulkoski-Gross; Wadie F Bahou; Stanley Zucker; Jian Cao
Journal:  J Natl Cancer Inst       Date:  2013-08-29       Impact factor: 13.506

2.  Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis.

Authors:  J M Lord; J Pongracz
Journal:  Clin Mol Pathol       Date:  1995-04

3.  Protein kinases and multidrug resistance.

Authors:  M G Rumsby; L Drew; J R Warr
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

4.  Inhibition of protein kinase C in multidrug-resistant cells by modulators of multidrug resistance.

Authors:  Y P Hu; J Robert
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

5.  Histone deacetylase inhibitors enhance the apoptotic activity of insulin-like growth factor binding protein-3 by blocking PKC-induced IGFBP-3 degradation.

Authors:  Seung Hyun Oh; Young Mi Whang; Hye-Young Min; Seung Ho Han; Ju-Hee Kang; Ki-Hoon Song; Bonnie S Glisson; Yeul Hong Kim; Ho-Young Lee
Journal:  Int J Cancer       Date:  2012-03-28       Impact factor: 7.396

6.  Protein kinase C isoform alpha overexpression in C6 glioma cells and its role in cell proliferation.

Authors:  G H Baltuch; N P Dooley; K M Rostworowski; J G Villemure; V W Yong
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.

Authors:  D K Ways; C A Kukoly; J deVente; J L Hooker; W O Bryant; K J Posekany; D J Fletcher; P P Cook; P J Parker
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Antisense expression of PKCalpha improved sensitivity of SGC7901/VCR cells to doxorubicin.

Authors:  Da-Long Wu; Feng-Ying Sui; Cheng Du; Cheng-Wen Zhang; Bin Hui; Shui-Ling Xu; Huan-Zhang Lu; Guo-Jie Song
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

9.  PKCalpha expression is a marker for breast cancer aggressiveness.

Authors:  Gry Kalstad Lønne; Louise Cornmark; Iris Omanovic Zahirovic; Göran Landberg; Karin Jirström; Christer Larsson
Journal:  Mol Cancer       Date:  2010-04-14       Impact factor: 27.401

10.  PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-beta1.

Authors:  Ying Chen; Guanzhen Yu; Danghui Yu; Minghua Zhu
Journal:  J Exp Clin Cancer Res       Date:  2010-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.